Abraxis vet Neil Desai gets Celgene backing for $23M A round; Two more biotechs set IPO terms
→ Celgene joined the syndicate backing a $23 million Series A for Pacific Palisades, CA-based Aadi Bioscience. The money will be used to support …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.